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Abstract
Lipid peroxidation (LPO) drives ferroptosis execution. However, LPO has been shown to contribute also to other
modes of regulated cell death (RCD). To clarify the role of LPO in different modes of RCD, we studied in a
comprehensive approach the differential involvement of reactive oxygen species (ROS), phospholipid peroxidation
products, and lipid ROS flux in the major prototype modes of RCD viz. apoptosis, necroptosis, ferroptosis, and
pyroptosis. LC-MS oxidative lipidomics revealed robust peroxidation of three classes of phospholipids during
ferroptosis with quantitative predominance of phosphatidylethanolamine species. Incomparably lower amounts of
phospholipid peroxidation products were found in any of the other modes of RCD. Nonetheless, a strong increase in
lipid ROS levels was detected in non-canonical pyroptosis, but only during cell membrane rupture. In contrast to
ferroptosis, lipid ROS apparently was not involved in non-canonical pyroptosis execution nor in the release of IL-1β
and IL-18, while clear dependency on CASP11 and GSDMD was observed. Our data demonstrate that ferroptosis is the
only mode of RCD that depends on excessive phospholipid peroxidation for its cytotoxicity. In addition, our results
also highlight the importance of performing kinetics and using different methods to monitor the occurrence of LPO.
This should open the discussion on the implication of particular LPO events in relation to different modes of RCD.
Introduction
Up to this day, multiple types of regulated cell death
(RCD) have been identified1. Excessive lipid peroxidation
(LPO) of polyunsaturated fatty acid (PUFA) containing
cell membrane phospholipids (PLs) has originally been
conceptualized as a hallmark of ferroptosis—an iron-
catalyzed mode of necrotic cell death2. Most ferroptosis
inducers rely on blocking the activity of glutathione per-
oxidase 4 (GPX4)—an enzyme able to reduce PL-
hydroperoxide (PL-OOH) to its alcohol form (PL-OH).
Consequently, PL-OOH upon reaction with labile iron
generates alkoxyl and peroxyl radicals, which further fuels
oxidation of PLs (oxPLs) in cellular membranes3. The
continued oxidation of PUFA-containing PLs is followed
by thinning and increased curvature of membrane,
thereby stimulating oxidative micellization, pore forma-
tion, and subsequent cell membrane rupture4.
Aside from ferroptosis, some specific LPO events have
also been described in apoptosis5, necroptosis6, and
pyroptosis7,8. Those studies, however, differ in terms of
used models and detection methods for LPO. To clarify
the role of LPO, in particular oxPLs, in different RCDs,
we subjected bone-marrow-derived macrophages
(BMDMs) to apoptosis, necroptosis, ferroptosis as well
as canonical and non-canonical pyroptosis and per-
formed liquid chromatography-mass spectrometry-
based redox-lipidomics analysis, further coined as the
oxidative lipidomics approach, a gold standard method
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to identify particular oxidized lipid species9. Addition-
ally, we utilized the properties of BODIPY™ 581/591
(C11-BODIPY) and dihydrorhodamine 123 (DHR123)
probes that change their fluorescence properties upon
oxidation. Oxidation of the polyunsaturated butadienyl
portion of C11-BODIPY results in a shift of the fluor-
escence emission peak from ~590 nm to ~510 nm. C11-
BODIPY resides in lipophilic membrane structures
where it can be oxidized by reactive enzymatic and/or
non-enzymatic pro-oxidant intermediates, including
alkoxyl and peroxyl radicals. Its oxidation is therefore an
indirect manifestation of the lipid ROS flux10, further
coined as lipid ROS. DHR123 on the other hand has been
used to measure intracellular reactive oxygen species
(ROS) levels particularly hydrogen peroxide (in the
presence of peroxidases) and oxidants derived from
peroxynitrite11. To the best of our knowledge, this is the
first systematic study that compares accumulation of
oxidized phospholipids (oxPLs), ROS and lipid ROS by
various methods on different modes of RCD.
Results
Predominant PL peroxidation products are detected in
ferroptosis, while incomparably lower levels in apoptosis,
necroptosis, and pyroptosis
To enable a comprehensive side by side comparison of
the role of oxPLs in the different modes of RCD in a single
cell type, we chose to work with primary BMDMs
because, depending on the trigger, these cells are able to
undergo apoptosis, necroptosis, pyroptosis and ferroptosis
(Supplementary Fig. 1a). To determine the role of oxPLs
in the execution of different modes of RCD, we subjected
BMDMs at the early stage of cell death (Supplementary
Fig. 1b) to oxidative lipidomics to evaluate in an unbiased
way oxPLs events preceding cell membrane permeabili-
zation. While specific oxPLs were detected in all types of
RCD compared to untreated samples, a magnitude higher
level of oxPLs was observed in ferroptotic cells (Fig. 1a, b).
Qualitative differences between samples confirmed the
unique profile of excessive oxPLs in ferroptosis. While in
apoptotic, necroptotic, and pyroptotic BMDMs mostly
oxidation of cardiolipin and/or phosphatidylcholine
were detectable (Fig. 1a), BMDMs undergoing ferroptosis
revealed mainly oxidized phosphatidylethanolamine
(oxPE) species followed by oxidized phosphatidylserine
(oxPS) and phosphatidylinositol (oxPI) (Fig. 1c). The
levels of oxidized phosphatidylcholine and cardiolipin in
ferroptosis-stimulated cells were not significantly different
from untreated samples (Fig. 1a). Remark that the over-
representation of oxPE could be due to its high relative
abundance compared to PS and PI (Fig. 1d). When the
relative oxidation rate per PL-species is calculated, PS is
relatively highest oxidized with oxPS representing up to
1.30% (Fig. 1e). Although, the comprehensive oxidative
lipidomics analysis in BMDMs revealed specific oxPLs
events in all prototypes of RCD, it is obvious that the
extend PL oxidation is a scale higher during ferroptosis as
reflected by the oxidation levels of mainly three PL-
species (PS, PI, and PE). Therefore, we propose to use the
term “excessive PL peroxidation” to refer to this extensive
signature of oxPLs during ferroptosis.
Increase in lipid ROS is an early event during ferroptosis,
while a late event during cell membrane rupture in non-
canonical pyroptosis
C11-BODIPY is generally used to monitor the flux of
lipid ROS in cell membranes, which is assumed to be
associated with a pro-oxidant activity and excessive PL
peroxidation e.g. during ferroptosis. In order to comple-
ment the above oxidative lipidomics fingerprints, we
performed a time-course analysis to monitor both ROS
and lipid ROS in all prototype modes of RCD in BMDMs.
Using a standardized gating strategy on non-
permeabilized cells (Supplementary Fig. 2a), we did not
detect an increase in lipid ROS in apoptosis and necrop-
tosis (Fig. 2a, b), while we observed a ~2-fold increase in
ROS (Fig. 2d, e). In sharp contrast, during ferroptosis both
an increase in ROS (up to 35-fold) and lipid ROS (4-fold)
was observed, which preceded cell death (Fig. 2c, f).
Similar results were obtained for fibroblast L929sAhFas
cells subjected to apoptosis, necroptosis, and ferroptosis
(Fig. 2g, Supplementary Fig. 2b–g). Unexpectedly, we
detected increased levels of lipid ROS in non-canonical,
but not in canonical pyroptosis (Fig. 2h, i) despite increase
of ROS (4-/5-fold) in both of them (Fig. 2j, k). Live cell
imaging revealed a differential lipid ROS signature viz.
during ferroptosis an early homogeneous staining pattern
preceding cell membrane rupture (Fig. 2l and Supple-
mentary Fig. 2h), and during non-canonical pyroptosis a
late patchy staining pattern is observed coinciding with
the cell membrane rupture (Fig. 2m and Supplementary
Fig. 2i). Similarly, flow cytometric analysis revealed high
levels of lipid ROS prior to cell membrane permeabiliza-
tion during ferroptotic, but not pyroptotic cells (Fig. 2n,
o). Overall, these data indicate an increased signature of
pro-oxidant activity (oxidative stress) in all prototype
forms of RCD, while a strong increase in lipid ROS is only
detected at the early phase of ferroptosis induction.
During non-canonical pyroptosis however, we only
detected an increase in lipid ROS signal at the late phase
coinciding with cell membrane rupture. This suggests that
specific peroxy-PL pro-death signals are only generated in
ferroptotic cells.
Lipid ROS during non-canonical pyroptosis is dependent
on CASP11 and GSDMD
To clarify the possible role of lipid ROS in cell mem-
brane rupture during non-canonical pyroptosis7, we
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utilized several genetic models of BMDMs targeting pyr-
optosis pathway. LPS-induced non-canonical pyroptosis is
mediated by caspase-11 activation, which then cleaves
gasdermin D (GSDMD) to generate the N-terminal
GSDMD p30 fragment that forms cytotoxic pores in the
plasma membrane12. Casp11-deficient BMDMs subjected
to LPS transfection were protected from cell death
(Fig. 3a) and did not show an increase in lipid ROS
(Fig. 3b). Similarly, the C11-BODIPY signal remained low
in gsdmd-deficient BMDMs (Fig. 3c, d), while ROS was
hardly affected (Fig. 3e). Lipid ROS was also absent in
BMDMs expressing a mutated form of GSDMD replacing
Ile to Asn at position 105 (gsdmdI105N/I105N)12 (Fig. 3g)
that undergoes cleavage (Fig. 3f) but is defective in pore
formation and cell death induction (Fig. 3h). This suggests
that the ability of GSDMD to create pores in the plasma
membrane crucially contributes to lipid ROS during non-
canonical pyroptosis. Live cell imaging further confirmed
the necessity of functional CASP11 and GSDMD in
generating lipid ROS during non-canonical pyroptosis
(Fig. 3i).
Lipid ROS is functionally involved in ferroptosis, but not in
pyroptosis execution
To assess the functional implication of lipid ROS or
oxPLs in cell death execution, we next performed a
genetic approach by overexpression GPX4 and as a
pharmacological approach using the lipophilic radical trap
Ferrostatin-1 (Fer1)3 to block LPO. While GPX4 over-
expression clearly inhibited the increase in lipid ROS in
ferroptotic BMDMs (Supplementary Fig. 3a, b), it failed to
reduce ROS and lipid ROS during non-canonical pyr-
optosis (Supplementary Fig. 3c–e), suggesting that lipid
ROS in this type of RCD does not originate from oxPLs.
When we supplemented BMDMs undergoing ferroptosis
and non-canonical pyroptosis with Fer1, we observed a
decrease in lipid ROS in both cell death modes (Fig. 4a, b,
e) due to scavenging capacity of Fer1 as well as compe-
tition with fluorescent probes in the oxidation process.
Importantly, only BMDMs stimulated with a ferroptosis
inducer were rescued from cell death (Fig. 4c, d, f).
Remark that ROS was not reduced by Fer1 during non-
canonical pyroptosis in contrast to ferroptosis (Fig. 4g),
which suggests that ROS and lipid ROS might be mutually
interlinked during ferroptosis but not during non-
canonical pyroptosis. Moreover, administration of Fer1
did not impact release of pro-inflammatory cytokines
from pyroptotic cells (Fig. 4h). In line with the observation
that lipid ROS is not increased in apoptosis, necroptosis,
and canonical pyroptosis, Fer1 did not have any impact on
the cell death execution (Fig. 4e, f). In conclusion, an early
increase in lipid ROS is involved in execution of ferrop-
tosis resulting in excessive generation of oxPLs, but not in
apoptosis, necroptosis, and pyroptosis.
Discussion
To the best of our knowledge, a comparative study on
the presence and role of excessive LPO in different modes
of RCD has not been reported. While LPO is the major
executioner mechanism in ferroptosis, it has also been
linked to apoptosis5, necroptosis6 and more recently to
pyroptosis7,8. Utilizing an unbiased oxidative lipidomics
approach, we showed (per)oxidation of PLs in all modes
of RCD with by far the highest levels of oxPL (mainly
oxPS, oxPE and oxPI) in ferroptosis. The commonly used
probe C11-BODIPY showed high increase in lipid ROS
during ferroptosis, but unexpectedly also during non-
canonical pyroptosis. While Fer1 blocks lipid ROS during
both ferroptosis and non-canonical pyroptosis, in contrast
to ferroptosis it does not affect non-canonical pyroptosis
suggesting that increase in lipid ROS is not implicated in
the pyroptosis execution.
It has been proposed that oxidation of PLs in ferroptosis
occurs in semi-specific manner making some oxPL more
prone to the oxidative process than others. PE has been
identified as a crucial PL oxidized during ferroptosis13.
However other PLs are also oxidized during ferropto-
sis13,14. In line with these findings, we detected oxPE,
oxPS and oxPI during ferroptosis in BMDMs. The high
levels of oxPS (1.30%) and lack of any oxPC despite its
dominant presence in BMDMs suggests also here some
specificity in the process. The length, number, and posi-
tion of double bounds in the lipid tails of the PLs are likely
determining factors in the progression and specificity of
PL oxidation.
Although lipid ROS typically initiates LPO, we detected
low only levels of two oxPLs in non-canonical pyroptosis,
at least at early stage of cell death induction (25%). Our
(see figure on previous page)
Fig. 1 Oxidative lipidomics analysis of BMDMs during apoptosis, necroptosis, ferroptosis and pyroptosis. a “Oxidative lipidomics” of BMDMs
subjected to apoptosis (4 h, 4000IU/ml hTNF and 5 μM TPCA-1), necroptosis (6 h, 4000IU/ml hTNF, 5 μM TPCA-1 and 10 μM zVAD.fmk), ferroptosis (4 h,
0.5 μM ML162), canonical pyroptosis (3 h of 1 µg/ml LPS followed by 30 min incubation with 5 mM ATP) and non-canonical pyroptosis (3 h of 1 µg/ml
LPS followed by 4 h incubation after LPS transfection). Only oxidized lipid species statistically different from untreated samples are plotted. b Level of
oxPLs analyzed by ‘oxidative lipidomics’ in BMDMs subjected to different types of RCD. c Level of oxPE, oxPS and oxPI in different modes of cell death.
d Percentage of different groups of PL in untreated BMDMs. e Percentage of oxPLs relative to their unoxidized counterparts. The combined results of
three biological replicates are shown. a, b Bars are mean ± SEM, one-way ANOVA, **p < 0.01, ****p < 0.0001.
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results show that C11-BODIPY fluorescence increase
coincides with cell membrane permeabilization and seems
to occur downstream of GSDMD-N pore formation. The
necessity of cleaved GSDMD in generating lipid ROS may
lay in its ability to permeabilise not only plasma mem-
brane, but also intracellular organelles including mito-
chondria15. Note also that live cell imaging showed a
granular intracellular C11-BODIPY staining during non-
canonical pyroptosis, in contrast to a homogenous stain-
ing pattern during ferroptosis. This might hint towards a
different source or mode of action of lipid ROS. Alter-
natively, oxidation of C11-BODIPY probe might not fully
reflect the state of membrane PL oxidation, as it was
demonstrated that C11-BODIPY may be more prone to
oxidation compared to lipids physiologically present in
cellular membranes16.
The differential LPO induction pending on the type of
pyroptosis may also have differential effects on the innate
immune system. Indeed, oxidized lipids have been asso-
ciated with anti-inflammatory signaling in macrophages17.
Moreover, caspase-11 dependent, but not caspase-1
dependent pyroptosis has been shown to induce ferritin
release from dying macrophages18. Ferritin serves as an
iron storage protein protecting cells from iron-catalyzed
oxidative stress by buffering the labile iron pool (LIP)19.
This drop of ferritin in dying BMDMs during non-
canonical pyroptosis might result in an increase LIP
boosting lipid ROS generation during the final stages of
cell rupture.
In line with our in vitro observations, Fer1 also failed to
rescue the observed sensitization of macrophage-specific
gpx4-deficient mice in model of cecal ligation and
puncture-induced shock8. One could expect that the
absence of GPX4 in macrophages sensitizes them for lipid
ROS and cell death at site of infection resulting in wor-
sening of the outcome. Recently, a role for ALOX5-
mediated LPO was proposed in non-canonical pyroptosis
upstream of inflammasome activation7. This might imply
that enzymatic, but not non-enzymatic LPO is involved in
non-canonical pyroptosis signaling. Note in this respect
that C11-BODIPY is generally used to detect non-
enzymatic, excessive lipid ROS in cellular membranes
rather than particular enzymatic LPO. Additionally, Fer1
has been shown to have limited ability to inhibit enzy-
matically driven LPO20. While excessive lipid ROS does
not have a role in non-canonical pyroptosis induction, it
cannot be excluded that specific, enzymatic LPO may
occur at the early stages of cell death and, similarly to
apoptosis5,
be indispensable for cell death progression.
C11-BODIPY has been described as a reliable tool to
measure excessive LPO in cells using flow cytometry and
fluorescent microscopy21, even though it does not reach the
specificity and sophistication of oxidative lipidomics22. So
far, C11-BODIPY has been used mostly in the context of
ferroptosis and can be useful in differentiating ferroptosis
from necroptosis and apoptosis. However, we advise some
caution using it in a more complex context of inflammation
in in vivo and in vitro because of the positivity of C11-
BODIPY in non-canonical pyroptotic death cells, which can
be circumvented by gating on living cells. In addition,
functional studies can be an extra strategy to clarify the
involvement of excessive LPO in the dying process by
analyzing the ability of lipophilic antioxidants to block lipid
ROS, and subsequent death. Finally, our data also show that
excessive generation of lipid ROS and oxPLs, which is
inhibitable by Fer1, is a hallmark of ferroptosis differ-
entiating it from apoptosis, necroptosis, and pyroptosis.
Materials and methods
Mice
Casp11−/− mice were generated by sequentially breed-
ing parental Casp4tm1b(KOMP)Wtsi mice (KOMP ID
CSD47499) with Flp-deleter mice to remove the Frt site
flanked LacZ reporter and Neomycin selection cassette,
and with Cre-deleter mice to remove LoxP site flanked
exons 3 and 4. Gsdmd−/− mice and GsdmdI105N mutant
(C57BL/6Janu-Gsdmdm1Anu/AnuApb) mice were kindly
provided by Dr. Vishva M. Dixit (Genentech) and the
Australian Phenomics Facility at the Australian National
University, respectively12. All mice were bred in specific
pathogen-free animal facilities and were females between
(see figure on previous page)
Fig. 2 Analysis of ROS and lipid ROS during apoptosis, necroptosis, ferroptosis, and pyroptosis. a–c Lipid ROS production during apoptosis
(4000IU/ml hTNF and 5 μM TPCA-1), necroptosis (4000IU/ml hTNF, 5 μM TPCA-1 and 10 μM zVAD.fmk) and ferroptosis (0.5 μM ML162) in BMDMs. d–f
ROS levels during apoptosis, necroptosis, and ferroptosis in BMDMs. g Lipid ROS and cell death in L929sAhFas cells in different modes of RDC,
heatmaps represent mean values from three independent experiments. h–i Lipid ROS during non-canonical (3 h of 1 µg/ml LPS followed by 8 h
incubation after LPS transfection) and canonical (3 h of 1 µg/ml LPS followed by 30 min incubation with 5 mM ATP) pyroptosis. j–k ROS during
canonical and non-canonical pyroptosis. l–m Representative fluorescent microscopy images of BMDMs undergoing ferroptosis and non-canonical
pyroptosis reaching ~30% of cell death, oxC11-BODIPY (oxidized) represents the levels of lipid ROS, while C11-BODIPY represents the level of staining
with the probe (unoxidized), DRAQ7 was used as a cell membrane permeabilization marker. n Analysis of C11-BODIPY signal intensity during
ferroptosis and non-canonical pyroptosis based on flow cytometry experiments. o Representative contour plots during flow cytometry
measurements of ferroptotic (3 h) and pyroptotic (8 h) BMDMs with stratification of the C11-BODIPY signal. All bars are mean ± SEM of at least three
biological replicates. One-way ANOVA, *, p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Fig. 3 Analysis of ROS and lipid ROS during non-canonical pyroptosis in genetic models targeting the pyroptosis pathway. a–b Cell
death and lipid ROS accumulation in casp11−/− BMDMs and WT 8 h after LPS transfection of LPS-primed cells. c–e Cell death, lipid ROS and ROS in
gsdmd−/− BMDMs during non-canonical pyroptosis. f Cleavage of WT and gsdmdI105N/I105N. g–h Lipid ROS and cell death of gsdmdI105N/I105N during
non-canonical pyroptosis. i Representative fluorescent microscopy images of WT, casp11−/−, gsdmd−/− and gsdmdI105N/I105N stained with C11-
BODIPY and DRAQ7 5 h after LPS transfection. All bars are mean ± SEM of three biological replicates. One-way ANOVA, *p < 0.05, **p < 0.01.
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8 and 12 weeks during all the experiments. Mice were
housed in air-conditioned, temperature-controlled rooms
with 14/10–h light/dark cycles. Food and water were
provided ad libitum. C57BL/6J WT mice were purchased
from Janvier (Le Genest, France). All mice experiments
were organized in accordance with institutional, national,
and European animal regulations.
Cell culture conditions
Primary macrophages were generated from bone-
marrow cells flashed out from femur and tibia. Cells
were differentiated to macrophages by culturing them in
Iscove’s modified Dulbecco’s medium (IMDM, Lonza)
with 10% (vol/vol) FBS, 30% (v/v) L929 cell-conditioned
medium, penicillin (100U/ml) and streptomycin (100 mg/
ml) for 6 days in 37 °C in the presence of 5% CO2. After
the differentiation, cells were detached using LPS free
10mM EDTA/PBS solution for specific experiments.
L929sAhFas cells were cultured in DMEM medium sup-
plemented with 10% of FBS (v/v) and L-glutamine (0.03%).
Cells were cultured in 37 °C in a humidified atmosphere
containing 5% CO2 and split every 3–4 days using trypsin/
EDTA solution.
Cell death analysis and cytokine measurements
Cell death was analyzed according to previously pub-
lished protocol23. Briefly, cells were seeded in 96-well
plate (10000/well) and stimulated for cell death next day.
For L929sAhFas cells, apoptosis was induced by admin-
istration of 125 ng/ml human anti-Fas antibody (clone
CH-11, BioConnect B.V., Huissen, Netherlands); necrop-
tosis was induced by 5000IU/ml of mouse TNF (VIB
Protein Service Facility, Gent, Belgium) and—optionally—
10 μM zVAD.fmk (VWR International, PA, USA); fer-
roptosis was induced by 10 μM of ML162 (Aobious,
Gloucester, MA, USA). For BMDMs, apoptosis was
induced by administration of 4000IU/ml hTNF (VIB
Protein Service Facility) and 5 μM TPCA-1 (Tocris
Bioscience, Bristol, UK), while necroptosis was induced by
additional supplementation with 10 μM zVAD.fmk. Fer-
roptosis was induced by 0.5 μM ML162. After adding
2.5 μM SytoxGreen (Molecular Probes, USA) and 33 μM
DEVD-amc (Peptanova, Sandhausen, Germany) fluores-
cence was measured every 1–2 h using FLUOstar Omega
(BMG Labtech). Cell death was calculated based on
fluorescence from 100% dead cells, killed by 0.5% of
TritonX. Pyroptosis in primary macrophages was induced
by 3 h priming cells with 1 µg/ml LPS, which was followed
either by addition of 5 mM ATP (canonical pyroptosis) or
LPS transfection using FuGENE® reagent (Promega,
Madison, WI, USA) (non-canonical pyroptosis). The mix
for transfection was prepared by 15min incubation of
2 µg/ml of LPS with FuGENE® according to the manu-
facturer’s protocol in room temperature. Mouse cytokines
in cell culture supernatants were determined by magnetic
bead-based multiplex assay using Luminex technology
(Bio-Rad, Hercules, CA, USA).
Oxidative lipidomics
Lipids were extracted by Folch procedure24 with slight
modifications, under nitrogen atmosphere, at all steps.
Lipid phosphorus was determined by a micro-method25
LC/ESI-MS analysis of lipids was performed on a Dionex
HPLC system coupled to an Orbitrap Fusion Lumos mass
spectrometer (ThermoFisher Scientific). PLs were sepa-
rated on a normal phase column (Luna 3 μm Silica (2)
100 A, 150 × 1.0 mm, (Phenomenex) at a flow rate of
0.050 ml/min. The column was maintained at 35 °C. The
analysis was performed using gradient solvents (A and B)
containing 10mM ammonium format. Solvent A con-
tained propanol:hexane:water (285:215:5, v/v/v) and sol-
vent B contained propanol:hexane:water (285:215:40, v/v/
v). The column was eluted for 0.5 min isocratically at 25%
B, then from 0.5 to 6.5 min with a linear gradient from 25
to 40% solvent B, from 6.5 to 25min using a linear gra-
dient from 40 to 55% solvent B, from 25 to 38min with a
linear gradient from 55 to 70% solvent B, from 38 to
48min using a linear gradient from 70 to 100% solvent B,
then isocratically from 48 to 55min at 100% solvent B
followed by a return to initial conditions from 55 to
70min from 100 to 25% B. The column was then equili-
brated at 25% solvent B for an additional 5min. The mass
spectrometer was operated with electrospray ionization
probe in negative polarity mode. Ion source conditions were
set as follows: Spray voltage = 3 kV, Sheath gas = 55
(arbitrary unit), Auxiliary gas = 10 (arb. unit), Sweep gas =
0.5 (arb. unit), Transfer tube temperature = 300 °C,
Vaporizer temperature = 200 °C, RF-Lens level = 20%.
Analysis of LC/MS data was performed using software
package Compound Discoverer™ (ThermoFisher) with an
(see figure on previous page)
Fig. 4 The effect of Fer1 on ferroptosis and non-canonical pyroptosis execution. a, b Lipid ROS accumulation during ferroptosis (0.5 μM ML162)
and non-canonical pyroptosis (3 h of 1 µg/ml LPS followed by 8 h incubation after LPS transfection) in the presence of 0.5 µM Fer1. c, d Cell death
levels during ferroptosis and non-canonical pyroptosis in the presence of Fer1. e–f Representative fluorescent microscopy images from BMDMs
undergoing different modes RCD showing the impact of Fer1 on lipid ROS and cell death. g The impact of Fer1 on ROS production during ferroptosis
and non-canonical pyroptosis. h The impact of Fer1 on production of pro-inflammatory cytokines. Heatmaps represent values from three biological
replicates. All bars are mean ± SEM of three biological replicates. One-way ANOVA, *p < 0.05, **p < 0.01, p < 0.0001.
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in-house generated analysis workflow and oxidized PL
database. Lipids were further filtered by retention time and
confirmed by fragmentation mass spectrum. Deuterated
PLs (Avanti Polar Lipids) were used as internal standards.
Flow cytometry measurements
L929sAhFas cells and BMDMs were seeded in 24-well
suspension plates (0.1mln/ml and 0.4mln/ml accordingly)
and stimulated for cell death. One hour before each time
point, fluorescent probes were added to proper wells:
0.5 μM C11-BODIPY (ThermoFisher, MA, USA) or 1 μM
DHR-123 (Cayman Chemical, MI, USA) and 0.5 μM of
DRAQ7 cell death stain (BioStatus, Shepshed, UK). Lipid
ROS and ROS accumulation was measured at specific
time points using BDFortessa. Fluorescence was collected
in B530 (C11-BODIPY and DHR123) and R780 (DRAQ7)
channels. Only fluorescence of not permeabilized cells
was analyzed. Gating strategy is presented in supple-
mentary materials (Supplementary Fig 1).
Microscopy experiments
BMDMs were seeded in 96-well plates (CellCarrier-96
ultra microplates, PerkinElmer, Waltham, MA, USA). Next
day, C11-BODIPY (2 µM) and DRAQ7 (0.5 µM) were
added to each well 15min before measurements. After
adding cell death inducers and Fer1, cell death was mea-
sured for 14 h every 30min using OPERA microscope using
20x magnification. Data were analyzed based on mean
fluorescence intensity of C11-BODIPY and DRAQ7 dyes.
Western blot analysis
Cells were denatured in Laemmli buffer by boiling for
10min. Separation of proteins was performed by SDS-
PAGE and proteins were transferred to nitrocellulose
membrane (Thermo Scientific) with semi-dry blotting.
Membrane was blocked using 5% non-fat dry milk solu-
tion in TBS buffer with 0.05% Tween20 (TBST). Incuba-
tion with primary antibody against GPX4 (1:1000; Abcam
ab125066), actin (1:5000, Bio-Connect B.V., Huissen,
Netherlands) and GSDMD antibody recognizing the
cleaved form26 was performed O/N at 4 °C in TBST. After
extensive washing, the membranes were incubated with
HRP-conjugated secondary anti-rabbit (1:5000; VWR
International, Oud-Hevererle, Belgium, NA934), anti-
mouse (1:5000; VWR International, NA931) for 1 h in
RT. Membranes were developed using Western Lighting
Enhanced Chemiluminescence Substrate (Perkin Elmer).
Statistical analysis
For the analysis of oxPLs during cell death, ROS and
lipid ROS measurement as well as cytokine measure-
ments, minimum three biological replicates were used.
For oxPL, lipid ROS, and ROS, data were analyzed by
ordinary one-way ANOVA with Tukey test for multiple
comparison. Data analysis of flow cytometry experiment
was performed using the FlowJo 10.7 software.
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